Patent No. EP4212515 (titled "Quinazolinones As Parp14 Inhibitors") was filed by Abbvie Biotechnology on Dec 20, 2018. The application was issued on Jul 19, 2023.

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents